Cargando…

COVID-19 vaccines and decreased transmission of SARS-CoV-2

A massive COVID-19 vaccination campaign is underway worldwide. Epidemiological data from studies indicate excellent efficacy and safety profile for COVID-19 vaccines. However, there are few data from studies on the effect of decreasing the probability of infection of vaccinated subjects compared to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vitiello, A., Ferrara, F., Troiano, V., La Porta, R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8287551/ https://www.ncbi.nlm.nih.gov/pubmed/34279767 http://dx.doi.org/10.1007/s10787-021-00847-2

Ejemplares similares

COVID-19 vaccination in pregnancy
por: Vitiello, Antonio, et al.
Publicado: (2021)

Breakthrough infections with the SARS-CoV-2 Delta variant: vaccinations halved transmission risk
por: Hsu, L., et al.
Publicado: (2022)

Brief review of the mRNA vaccines COVID-19
por: Vitiello, Antonio, et al.
Publicado: (2021)

Tear antibodies to SARS‐CoV‐2: implications for transmission
por: Selva, Kevin J, et al.
Publicado: (2021)

Potential secondary transmission of SARS-CoV-2 via wastewater
por: Liu, Dasheng, et al.
Publicado: (2020)

Household crowding hampers mitigating the transmission of SARS-CoV-2
por: Villela, Daniel Antunes Maciel
Publicado: (2021)

Genomic epidemiological analysis of SARS-CoV-2 household transmission
por: Hare, Daniel, et al.
Publicado: (2021)

SARS-CoV-2 transmission dynamics in the urban-rural interface
por: Polo, G., et al.
Publicado: (2022)

Pregnancy and COVID-19, focus on vaccine and pharmacological treatment
por: Vitiello, Antonio, et al.
Publicado: (2022)

Recreational waters – A potential transmission route for SARS-CoV-2 to humans?
por: Cahill, Niamh, et al.
Publicado: (2020)

Cell morphological analysis of SARS-CoV-2 infection by transmission electron microscopy
por: Zhao, Jin, et al.
Publicado: (2020)

SARS-CoV-2 infection in fully vaccinated healthcare workers
por: Hernández Porto, Miriam, et al.
Publicado: (2022)

Humoral and adaptive immune responses to the SARS-CoV-2 vaccine
por: Rizzo, Roberta, et al.
Publicado: (2022)

COVID-19 Vaccination Safety in Patients who have had SARS-CoV-2-induced Chilblains
por: POIZEAU, Florence, et al.
Publicado: (2022)

Epigallocatechin-3-gallate (EGCG): a potential molecule for the development of therapeutics against emerging SARS-CoV-1, MERS-CoV and SARS-CoV-2 coronaviruses
por: Joseph, Jeswin, et al.
Publicado: (2021)

Syncope at SARS-CoV-2 onset
por: Canetta, Ciro, et al.
Publicado: (2020)

Modeling strategies for the allocation of SARS-CoV-2 vaccines in the United States
por: Walker, Joseph, et al.
Publicado: (2022)

Exacerbation of Hailey-Hailey Disease Following SARS-CoV-2 Vaccination
por: ARMONI-WEISS, Gil, et al.
Publicado: (2021)

Vaccination against SARS-CoV-2 in a rural Ugandan population
por: Mugisha, Joseph, et al.
Publicado: (2023)

NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challenge
por: Guebre-Xabier, Mimi, et al.
Publicado: (2020)

The assessment of transmission efficiency and latent infection period in asymptomatic carriers of SARS-CoV-2 infection
por: Liu, Zhirong, et al.
Publicado: (2020)

Community transmission of SARS-CoV-2 with B.1.1.7 lineage in Mumbai, India
por: Shastri, Jayanthi, et al.
Publicado: (2022)

Ototoxicity prevention during the SARS-CoV-2 (COVID-19) emergency
por: Ciorba, Andrea, et al.
Publicado: (2020)

SARS‐CoV‐2 spike mRNA vaccine sequences circulate in blood up to 28 days after COVID‐19 vaccination
por: Castruita, Jose Alfredo Samaniego, et al.
Publicado: (2023)

Ameliorated immunity elicited by intradermal inoculation in individuals vaccinated with inactivated SARS-CoV-2 vaccine
por: Fan, Shengtao, et al.
Publicado: (2021)

Vaccine breakthrough infections with SARS-CoV-2: Why older adults need booster vaccinations
por: Ventura, Maria I., et al.
Publicado: (2022)

The renin-angiotensin system and specifically angiotensin-converting enzyme 2 as a potential therapeutic target in SARS-CoV-2 infections
por: Ferrara, Francesco, et al.
Publicado: (2021)

Cross neutralization of SARS‐CoV‐2 omicron subvariants after repeated doses of COVID‐19 mRNA vaccines
por: Luczkowiak, Joanna, et al.
Publicado: (2022)

Testicular pain as an unusual presentation of COVID-19: a brief review of SARS-CoV-2 and the testis
por: La Marca, Antonio, et al.
Publicado: (2020)

Perspectives of association Baricitinib/Remdesivir for adults with Covid-19 infection
por: Vitiello, Antonio, et al.
Publicado: (2021)

Low immunogenicity to SARS-CoV-2 vaccination among liver transplant recipients
por: Rabinowich, Liane, et al.
Publicado: (2021)

Heterogeneous immunogenicity of SARS-CoV-2 vaccines in cancer patients receiving radiotherapy
por: Bowes, Cynthia L., et al.
Publicado: (2022)

Sars-CoV2 vaccine hesitancy in Italy: A survey on subjects with diabetes
por: Scoccimarro, Daniele, et al.
Publicado: (2021)

Effects of SARS-CoV-2 vaccination on blood donation and blood banks in India
por: Hunain, Reem, et al.
Publicado: (2022)

The early impact of vaccination against SARS-CoV-2 in Region Stockholm, Sweden
por: Isitt, Catherine, et al.
Publicado: (2022)

SARS-CoV-2 antibody determination in a vaccinated and recovered cohort in Austria
por: Mara, Elisabeth, et al.
Publicado: (2022)

Viral aerosol transmission of SARS-CoV-2 from simulated human emission in a concert hall
por: Schade, Wolfgang, et al.
Publicado: (2021)

Transmissibility of SARS-CoV-2 Variants as a Secondary Attack in Thai Households: a Retrospective Study
por: Watanapokasin, Natcha, et al.
Publicado: (2021)

Contribution of VitaPCR SARS-CoV-2 to the emergency diagnosis of COVID-19
por: Fournier, Pierre-Edouard, et al.
Publicado: (2020)

Sensitive on-site detection of SARS-CoV-2 by ID NOW COVID-19
por: Krause, Eva, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7reniqkccdul5hg73kq57natdg